AYN — Global Testing Cashflow Statement
0.000.00%
- SG$37.41m
- SG$10.84m
- $41.52m
- 95
- 90
- 86
- 100
Annual cashflow statement for Global Testing, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.417 | 7.74 | 12.1 | 3.89 | 5.42 |
Depreciation | |||||
Non-Cash Items | -0.442 | -0.015 | -0.229 | -0.659 | -0.722 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.08 | -1.5 | 1.77 | 0.976 | -1.25 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 6.56 | 13.5 | 20 | 10.4 | 9.25 |
Capital Expenditures | -3.25 | -5.51 | -7.84 | -5.4 | -6.73 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.97 | 0.108 | 0 | -9.02 | 6.01 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -2.28 | -5.41 | -7.84 | -14.4 | -0.715 |
Financing Cash Flow Items | -0.172 | -0.065 | -0.008 | -2.58 | -1.29 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2.18 | -2.06 | -6.05 | -2.78 | -2.23 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.1 | 6.02 | 6.08 | -6.79 | 6.31 |